Bladder Cancer Canada is thrilled to announce the 2025 BCC Volunteer Award recipients! Their dedication and hard work have made a meaningful impact on the bladder cancer community, setting a new standard of excellence in volunteerism.
A big thank you to everyone who nominated and supported this year’s award program. Your involvement helps honour the volunteers who go above and beyond to make a difference in the lives of those affected by bladder cancer.

“As a new volunteer, Iffah has made an extraordinary and immediate impact on Bladder Cancer Canada’s mission to increase awareness, build community, and raise critical funds. She didn’t just fill a role; she embraced our cause with entrepreneurial spirit and remarkable dedication, significantly advancing our presence in Brampton, ON.”

“Daniel’s impact on Bladder Cancer Canada has been both wide-reaching and transformative. Since September 2023, he has served as both Kingston Walk Lead and student leader of the Queen’s University Bladder Cancer Awareness Club, ensuring year-round presence for BCC on campus and in the community. His service combines event leadership, community outreach, and logistical commitment.”

“Robert has been a long-term BCC volunteer of over 8 years. He has gone above and beyond his role as a Peer Support Volunteer by also engaging with Bladder Cancer Canada’s other initiatives, such as the annual Belleville Walk and sharing his story on the BCC podcast. Rob is a strong advocate for bladder cancer patients, both in his local community and nationally. He is always quick to respond, and happy to to help, as well as provide compassion and reassurance to someone newly diagnosed.”

“Tony exemplifies every quality recognized by this award – and so much more. Tony’s leadership and commitment to BCC, and to people affected by bladder cancer, extend far beyond Board service. His dedication shows up in every volunteer he takes on – and in many he actively helps create. His engagement nationally, and with the medical & research communities has elevated the patient voice, particularly for those living with metastatic disease, and those seeking clinical trials.”

“Steve was a wealth of knowledge and a pillar of support not only to us but, I am certain, to countless others. His dedication to the cause, his advocacy for the foundation, and the personal encouragement he offered were invaluable. He had a gentle, thoughtful way of making people feel seen and supported – a quality that is rare and deeply appreciated in moments of uncertainty and fear.”







